Related Experiment Video
Updated: Oct 10, 2025
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Genetic Analysis for Coronary Artery Disease Toward Diverse Populations
1Laboratory for Cardiovascular Genomics and Informatics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Insights
Genetic analyses for coronary artery disease (CAD) have evolved from family studies to genome-wide association studies, identifying susceptibility loci and rare variants. This advances understanding of disease mechanisms, genetic risk, and therapeutic development for CAD.
Area of Science:
- Cardiovascular Genetics
- Genomics
- Disease Mechanisms
Background:
- Coronary artery disease (CAD) is a major global cause of mortality.
- Genetic studies for CAD have historically focused on familial early-onset conditions like familial hypercholesterolemia.
- The advent of genome-wide association studies (GWAS) has significantly advanced CAD research.
Purpose of the Study:
- To review current genetic analysis approaches for coronary artery disease.
- To highlight key advancements in identifying CAD susceptibility loci and genetic risk.
- To discuss the implications of genetic findings for understanding disease mechanisms and developing therapeutics.
Main Methods:
- Review of genetic analysis methodologies in coronary artery disease research.
- Discussion of findings from family-based studies and genome-wide association studies (GWAS).
- Consideration of technological advancements enabling identification of rare genetic variants in population-based analyses.
Main Results:
- Identification of numerous genetic loci associated with coronary artery disease susceptibility.
- Advancements in understanding detailed disease mechanisms through genetic insights.
- Enabling quantification of individual genetic risk for coronary artery disease.
- Facilitating the development of novel therapeutic agents targeting genetic pathways.
Conclusions:
- Genetic analyses have become crucial for understanding coronary artery disease.
- Current technologies allow for comprehensive genetic risk assessment and personalized medicine approaches.
- Continued genetic research promises further breakthroughs in CAD prevention and treatment.
Abstract:
Coronary artery disease is one of the leading causes of death in the world, and as such, it is one of the diseases for which genetic analyses have been actively conducted. In the early days, analyses of families with the aggregation of early-onset myocardial infarction, such as those with familial hypercholesterolemia, was the main focus, but since the practical application of genome-wide association study, the analysis of coronary artery disease as a common disease has progressed, and many disease-susceptibility loci have been identified. In addition, with the advancement of technologies, it has become possible to identify relatively rare genetic variants in a population-based analysis. These advances have not only revealed the detailed disease mechanisms but have also enabled the quantification of individual genetic risk and the development of new therapeutic agents. In this paper, some of those items, which are important to know in the current genetic analyses for coronary artery disease, are discussed.
More Related Videos
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
01:11Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
01:26Coronary Artery Disease II: Pathophysiology
01:30Coronary Artery Disease III: Clinical Manifestations
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:26Coronary Artery Disease IV: Preventive Measures